{"id":4742,"date":"2020-07-14T21:22:07","date_gmt":"2020-07-14T21:22:07","guid":{"rendered":"http:\/\/blogs.sld.cu\/oserranob\/?p=4742"},"modified":"2020-07-14T21:22:07","modified_gmt":"2020-07-14T21:22:07","slug":"farmacogenomica-del-trastorno-bipolar","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2020\/07\/14\/farmacogenomica-del-trastorno-bipolar\/","title":{"rendered":"Farmacogen\u00f3mica del trastorno bipolar"},"content":{"rendered":"<p style=\"text-align: justify\"><a href=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2020\/07\/IJBD.jpg\"><img loading=\"lazy\" class=\" size-full wp-image-4743 alignleft\" style=\"border-width: 1px;margin: 5px\" src=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2020\/07\/IJBD.jpg\" alt=\"IJBD\" width=\"85\" height=\"112\" \/><\/a>Una revisi\u00f3n que resume los principales elementos sobre las posibles dianas farmacogen\u00f3micas, los estudios de asociaci\u00f3n y los ensayos farmacogen\u00e9ticos relativos al tratamiento del <a title=\"Informaci\u00f3n de la enfermedad en OMIM\" href=\"https:\/\/omim.org\/entry\/125480\" target=\"_blank\">trastorno bipolar<\/a> puede ser consultado en Cu\u00e9llar-Barboza AB, McElroy SL, Veldic M, Singh B, Kung S, Romo-Nava F, <em>et al<\/em>. <a title=\"Texto completo en ingl\u00e9s\" href=\"https:\/\/journalbipolardisorders.springeropen.com\/articles\/10.1186\/s40345-020-00184-3\" target=\"_blank\">Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection<\/a>. International Journal of Bipolar Disorders 2020;8:23.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Una revisi\u00f3n que resume los principales elementos sobre las posibles dianas farmacogen\u00f3micas, los estudios de asociaci\u00f3n y los ensayos farmacogen\u00e9ticos relativos al tratamiento del trastorno bipolar puede ser consultado en Cu\u00e9llar-Barboza AB, McElroy SL, Veldic M, Singh B, Kung S, Romo-Nava F, et al. Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[15,19,23,29],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/4742"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=4742"}],"version-history":[{"count":1,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/4742\/revisions"}],"predecessor-version":[{"id":4744,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/4742\/revisions\/4744"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=4742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=4742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=4742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}